New nerve block aims to stop chronic pain after mastectomy
NCT ID NCT07289178
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a single injection of liposome bupivacaine, a long-acting anesthetic, into the chest wall can reduce pain sensitivity and prevent chronic pain after radical mastectomy. 120 breast cancer patients will receive the nerve block during surgery, and their pain thresholds and pain scores will be tracked for 6 months. The goal is to see if this approach can improve recovery and lower the risk of lasting pain.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
liposome bupivacaine
What this could lead to
If it works, this could provide a way to reduce long-term pain after mastectomy, improving recovery and quality of life for breast cancer patients.
What could go wrong
This is an early-phase study with only 120 participants, so results may not apply to everyone. The nerve block may not significantly reduce chronic pain, and there are risks like allergic reaction or infection.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
First Affiliated Hospital of Kunming Medical University
Kunming, Yunnan, 650000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••